These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bacteriophages as anti-infective agents: recent developments and regulatory challenges. Gilmore BF Expert Rev Anti Infect Ther; 2012 May; 10(5):533-5. PubMed ID: 22702317 [TBL] [Abstract][Full Text] [Related]
8. Use of phages to control Campylobacter spp. Janež N; Loc-Carrillo C J Microbiol Methods; 2013 Oct; 95(1):68-75. PubMed ID: 23830848 [TBL] [Abstract][Full Text] [Related]
10. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. Golkar Z; Bagasra O; Pace DG J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621 [TBL] [Abstract][Full Text] [Related]
11. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches. Chanishvili N Adv Virus Res; 2012; 83():3-40. PubMed ID: 22748807 [TBL] [Abstract][Full Text] [Related]
12. What is needed for phage therapy to become a reality in Western medicine? Brüssow H Virology; 2012 Dec; 434(2):138-42. PubMed ID: 23059181 [TBL] [Abstract][Full Text] [Related]
13. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779 [TBL] [Abstract][Full Text] [Related]
14. Back to the future: bacteriophages as promising therapeutic tools. Domingo-Calap P; Georgel P; Bahram S HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965 [TBL] [Abstract][Full Text] [Related]
15. European regulatory conundrum of phage therapy. Verbeken G; De Vos D; Vaneechoutte M; Merabishvili M; Zizi M; Pirnay JP Future Microbiol; 2007 Oct; 2(5):485-91. PubMed ID: 17927471 [TBL] [Abstract][Full Text] [Related]
16. A game of resistance: War between bacteria and phages and how phage cocktails can be the solution. Costa P; Pereira C; Romalde JL; Almeida A Virology; 2024 Nov; 599():110209. PubMed ID: 39186863 [TBL] [Abstract][Full Text] [Related]
18. The next generation of bacteriophage therapy. Lu TK; Koeris MS Curr Opin Microbiol; 2011 Oct; 14(5):524-31. PubMed ID: 21868281 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. Ryan EM; Gorman SP; Donnelly RF; Gilmore BF J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540 [TBL] [Abstract][Full Text] [Related]
20. Phage therapy: past history and future prospects. Carlton RM Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]